Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3511639 | 1.00 | HDAC6 (0.50) | HDAC6NLRP3 | |
| SCHEMBL15444385 | 0.85 | HDAC6 (0.55) | HDAC6 | |
| SCHEMBL3510752 | 0.82 | NLRP3 (0.40) | NLRP3 | |
| SCHEMBL12420173 | 0.81 | HDAC6 (0.59) | HDAC6 | |
| SCHEMBL14153661 | 0.81 | HDAC6 (0.59) | HDAC6 | |
| SCHEMBL713065 | 0.81 | HDAC6 (0.59) | HDAC6 | |
| SCHEMBL1890724 | 0.81 | HDAC6 (0.59) | HDAC6 | |
| SCHEMBL17590204 | 0.81 | HDAC6 (0.59) | HDAC6 | |
| SCHEMBL19657980 | 0.78 | HDAC6 (0.59) | HDAC6 | |
| SCHEMBL532329 | 0.72 | HDAC6 (0.60) | HDAC6NLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8710013-B2 | Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use | ANGIOCHEM INC. (CA) | 2014-04-29 | — | — | US | claimed |
| US-20180015180-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC (CA) | 2018-01-18 | — | — | US | disclosed |
| EP-2588490-B1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC (CA) | 2017-02-22 | — | — | EP | disclosed |
| US-20160263236-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC (CA) | 2016-09-15 | — | — | US | disclosed |
| US-9161988-B2 | Multimeric peptide conjugates and uses thereof | ANGIOCHEM INC. (CA) | 2015-10-20 | — | — | US | disclosed |
| US-8710013-B2 | Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use | ANGIOCHEM INC. (CA) | 2014-04-29 | — | — | US | disclosed |
| US-20130280281-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2013-10-24 | — | — | US | disclosed |
| US-20120141416-A1 | MULTIMERIC PEPTIDE CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2012-06-07 | — | — | US | disclosed |
| US-20110112036-A1 | PHARMACEUTICAL COMPOSITIONS OF PACLITAXEL, PACLITAXEL ANALOGS OR PACLITAXEL CONJUGATES AND RELATED METHODS OF PREPARATION AND USE | ANGIOCHEM INC. (CA) | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120141416-A1 | MULTIMERIC PEPTIDE CONJUGATES AND USES THEREOF | LNPEP, DNPEP, VIP | HDAC6 1097/4885NLRP3 1887/4885 |
| US-20110112036-A1 | PHARMACEUTICAL COMPOSITIONS OF PACLITAXEL, PACLITAXEL ANALOGS OR PACLITAXEL CONJUGATES AND RELATED METHODS OF PREPARATION AND USE | PGA5, KIF5A, ABCB11 | HDAC6 2193/4885NLRP3 4740/4885 |
| US-20130280281-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | SLC43A1, SLC7A5, DNPEP | HDAC6 1719/4885NLRP3 3107/4885 |
| US-20180015180-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | SLC43A1, SLC7A5, DNPEP | HDAC6 1719/4885NLRP3 3107/4885 |
| US-20160263236-A1 | SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF | SLC43A1, SLC7A5, DNPEP | HDAC6 1719/4885NLRP3 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.